CA52818-1 - 0x000000000000702F

Males & Females of Non-Childbearing Potential

Marvelous

* Stipend may pay up to reflected amount.
Start Date: 
July 30, 2026 - 3:00pm
End Date: 
September 25, 2026 - 9:30am

Study Details

Study Number: CA52818
Group Number: 1
Study Requirement: Healthy Normal Male and Female
Stipend: up to $6,000.00

Study Criteria

Age: 19 - 55
BMI: 0 - 0
Weight Restriction: minimum weight 0 lbs

Study Information

Indication: This investigational medication is being developed to treat infammatory bowel disease.
Route of Administration: Injection IV infusion
Blood Draws: 12

Study Schedule

Schedule Type: Short stays with returns
Study Length: 2 Night Stay & 5 Returns

Screening Dates:

Event Day Event Date
Thursday 7/16/2026
Monday 7/20/2026
Thursday 7/23/2026
Monday 7/27/2026
Wednesday 7/29/2026

Doctor Exam Dates:

Event Day Event Date
Thursday 7/16/2026
Monday 7/20/2026
Thursday 7/23/2026
Monday 7/27/2026
Wednesday 7/29/2026

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Check-In Thursday 7/30/2026 3:00:00 PM Saturday 8/1/2026 10:30:00 AM 1 Lincoln
Return Thursday 8/6/2026 8:30:00 AM Thursday 8/6/2026 9:30:00 AM 1 Lincoln
Return Friday 8/14/2026 8:30:00 AM Friday 8/14/2026 9:30:00 AM 1 Lincoln
Return Friday 8/28/2026 8:30:00 AM Friday 8/28/2026 9:30:00 AM 1 Lincoln
Return Friday 9/11/2026 8:30:00 AM Friday 9/11/2026 9:30:00 AM 1 Lincoln
Return Friday 9/25/2026 8:30:00 AM Friday 9/25/2026 9:30:00 AM 1 Lincoln